Ximluci 10 mg/mL Solution for Intravitreal Injection contains ranibizumab, an anti-VEGF medicine used in the treatment of retinal disorders that may affect vision. Each vial contains 2.3 mg ranibizumab in 0.23 mL sterile solution, providing a usable amount for a single intravitreal injection administered by an eye specialist.

Product Highlights:
Contains ranibizumab 10 mg/mL
Anti-VEGF ophthalmic treatment
Sterile solution for intravitreal injection
0.23 mL single-use vial with filter needle
Biosimilar to ranibizumab reference products
For administration by an ophthalmologist only

How To Use:
Ximluci must be administered by a qualified ophthalmologist using appropriate aseptic intravitreal injection techniques. Follow your eye specialist's treatment schedule and attend all recommended follow-up appointments.

Warnings:
Use only under medical supervision. Do not use if you have an active eye infection, inflammation in or around the eye, or a known allergy to ranibizumab or any of the product ingredients. Seek immediate medical attention if you experience severe eye pain, worsening redness, sudden vision changes, flashes of light, increased floaters, or signs of infection after treatment.

Common Side Effects:
Eye pain, eye redness, increased intraocular pressure, floaters, blurred vision, dry eyes, watery eyes, eye irritation, and headache.

Disclaimer:
This information is provided for educational and product identification purposes only and does not replace professional medical advice, diagnosis, or the approved prescribing information.